HomeRegulatory & Legal
- EMA: CHMP adopted a positive opinion for Fasenra (benralizumab) 30-mg solution for inje...
- EMA: CHMP adopted a positive opinion for Ocrevus (ocrelizumab) 300-mg concentrate for s...
- EMA: CHMP adopted a positive opinion for Intrarosa (prasterone) 6.5 mg pessary from End...
- MoH: Draft of Government` Emergency Ordinance amending and supplementing Law 95/2006 o...
- MoH: Order 1.203 of October 16, 2017 to amend the MoH Order 2.071 / 2008 approving the ...
- MoH: Order 871/1.300/104/2017 for amending Annexes 1 and 2 of the Order of the Minister...
- NMA: For the attention of Pharmacies, Hypermarkets, Supermarkets, Online Distribution C...
- NMMDA: Announcement on modifying the response to Customs requirements for Medical Devices
- MoH: Draft Order for completing the Order of the Minister of Health 449/2015 on the app...
- MoH : Draft Order for the approval of methodological guidelines for the implementation ...
- MoH: Draft Human Transplant Law
- MoH: Draft Order for completing Annex no. 1 of MoH Order 477/2009 on the establishment ...
- MoH: Draft Order for amending and completing the Order no. 1378/2287 of 2011 for the ap...
- MoH: Order on composition, attributions, regulation of organization and functioning of ...
- MoH: Government Decision on information on the amount of health insurance contribution ...
- MoH: Government Decision on amending some normative acts related to the Program for 90%...
Trends and developments
Apr
01
2023
-
Government Decision (GD) for updating the organization and functioning of Ministry of Health
GD published in the Official Gazette is updating the personnel and cars numbers within Ministry of Health. -
The highest clawback level recorded in the last quarter of the year
NHIH published the total value of reimbursed medicines in the fourth quarter of 2016. -
HAS has re-issued drugs for Alzheimer disease
HAS has published online, on 25th of January, its new evaluation regarding drugs for Alzheimer’s disease. -
NICE Guidance: Mepolizumab for treating severe refractory eosinophilic asthma
Technology appraisal guidance [TA431], published on 25 January 2017 -
NICE Guidance: Sofosbuvir-velpatasvir for treating chronic hepatitis C
Technology appraisal guidance [TA430], published on 25 January 2017
